ALEJANDRO
MOLINA LEYVA
Ikertzailea 2022-2023 tartean
Hospital Universitario Marqués de Valdecilla
Santander, EspañaHospital Universitario Marqués de Valdecilla -ko ikertzaileekin lankidetzan egindako argitalpenak (1)
2023
-
Reply to: “Comment on ‘Interruption of oral clindamycin plus rifampicin therapy in patients with hidradenitis suppurativa: An observational study to assess prevalence and causes’”
Journal of the American Academy of Dermatology